Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid Tumor Pediatric”

329 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 329 results

Early research (Phase 1)UnknownNCT02897986
What this trial is testing

Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors

Who this might be right for
Pediatric Cancer
Assistance Publique Hopitaux De Marseille 54
Early research (Phase 1)Study completedNCT01875601
What this trial is testing

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

Who this might be right for
Solid TumorsBrain TumorsSarcoma+2 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT04508400
What this trial is testing

Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients

Who this might be right for
Pediatric Cancer
Sun Yat-sen University 108
Not applicableStudy completedNCT02505165
What this trial is testing

Illness Management and Parental Adjustment to Cancer Treatment

Who this might be right for
Solid TumorLeukemiaLymphoma+1 more
Children's Hospital Medical Center, Cincinnati 279
Early research (Phase 1)Study completedNCT03215511
What this trial is testing

Test the Safety of the Investigational Drug Selitrectinib in Children and Adults That May Treat Cancer

Who this might be right for
Solid Tumors Harboring NTRK Fusion
Bayer 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT04320888
What this trial is testing

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmRecurrent EpendymomaRecurrent Ewing Sarcoma+35 more
National Cancer Institute (NCI) 1
Early research (Phase 1)Looking for participantsNCT06612645
What this trial is testing

Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors

Who this might be right for
Pediatric CancersSolid Tumor Pediatric
Chulalongkorn University 9
Not applicableStudy completedNCT03686566
What this trial is testing

Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]

Who this might be right for
NeuroblastomaSarcomaPediatric Cancer
University of Texas Southwestern Medical Center 84
Early research (Phase 1)Study completedNCT01049841
What this trial is testing

Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors

Who this might be right for
Pediatric Solid Tumors
Memorial Sloan Kettering Cancer Center 23
Early research (Phase 1)Looking for participantsNCT02508038
What this trial is testing

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more
University of Wisconsin, Madison 22
Early research (Phase 1)Ended earlyNCT00003926
What this trial is testing

Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorChordoma+6 more
Masonic Cancer Center, University of Minnesota 13
Early research (Phase 1)Study completedNCT02982941
What this trial is testing

Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors

Who this might be right for
NeuroblastomaRhabdomyosarcomaOsteosarcoma+3 more
MacroGenics 25
Testing effectiveness (Phase 2)Looking for participantsNCT04570423
What this trial is testing

Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy

Who this might be right for
Solid TumorsLymphoma
Spectrum Pharmaceuticals, Inc 40
Post-approval studies (Phase 4)Study completedNCT00230217
What this trial is testing

Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy

Who this might be right for
TumorsHyperuricemiaTumor Lysis Syndrome
Sanofi 94
Not applicableUnknownNCT04773808
What this trial is testing

Molecular Characterization of Genetic Alterations in Pediatric Solid Tumors

Who this might be right for
Pediatric Solid Tumors
National Council of Scientific and Technical Research, Argentina 100
Testing effectiveness (Phase 2)UnknownNCT02787876
What this trial is testing

Pegteograstim in Children With Solid Tumors

Who this might be right for
Chemotherapy Induced NeutropeniaPediatric Solid Tumor
Samsung Medical Center 34
Very early researchStudy completedNCT03445858
What this trial is testing

Pembrolizumab in Combination With Decitabine and Hypofractionated Index Lesion Radiation in Pediatrics and Young Adults

Who this might be right for
Childhood Solid TumorChildhood LymphomaRelapsed Cancer+3 more
Children's Hospital Medical Center, Cincinnati 22
Testing effectiveness (Phase 2)Looking for participantsNCT04094610
What this trial is testing

Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more
Turning Point Therapeutics, Inc. 75
Large-scale testing (Phase 3)Study completedNCT02910726
What this trial is testing

A Study Comparing Green Fluorescent Dye and Radioactive Dye for Sentinel Lymph Node Biopsy in Pediatric Cancers

Who this might be right for
Pediatric Patients With Solid Tumors
Memorial Sloan Kettering Cancer Center 6
Not applicableLooking for participantsNCT05151718
What this trial is testing

Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

Who this might be right for
Ependymoma of BrainPediatric Solid Tumor
Institut Claudius Regaud 370
Next Page